OWC Pharmaceutical Research Corp (OWCP)

[FELLER]

Miri Sani has more than 20 years of experience in the Israeli Biotech industry and has worked in several companies as VP of regulatory affairs. As part of her responsibilities, Ms. Sani has designed and conducted many clinical studies. She also led the process of the FDA and CE mark approvals. Ms. Sani served as VP of Regulatory Affairs in Notal Vision that developed solutions for the early detection and monitoring of Age-Related Macular Degeneration (AMD), ConTipi that provided female urine incontinence solutions, and MTRE that developed a thermoregulation system for surgeries. In addition, Ms. Sani is a CEO of a consulting company, Shefa Amirim Med, which has designed and conducted clinical studies for Israeli, incubator-based companies all over the world. In addition, she serves a a regulatory director in several Israeli biotech companies.